Germany's Symrise says potential unit sale, Swedencare impairment to hurt earnings
German fragrances maker Symrise AG said on Monday it is in advanced talks to sell its terpenes business and that it would take a non-cash impairment of about 145 million euros ($169.22 million) related to the sale in the fourth quarter.